DemeCAPRONE - Suture, poliglecaprone
Access comprehensive regulatory information for DemeCAPRONE - Suture, poliglecaprone in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is sponsored by Avacare Australia Pty Ltd, manufactured by DemeTECH Corp in United States of America. The device registration started on January 17, 2023.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.
DemeCAPRONE (POLIGLECAPRONE 25) synthetic absorbable sutures are indicated for use in general soft tissue approximation and/or ligation, but not for use in cardiovascular or neurological surgery, microsurgery, or ophthalmic surgery.